| LNTH Snapshot | |
|---|---|
| Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts. | |
| VALUATION DATA | |
| Market Capitalization | $4,381,120,000 | Price to Sales | 1.00 |
| Earnings per Share | $4.6500 |
| PE Ratio | 13.74 |
| PRICE DATA | |
| Most Recent Close | $65.2000 |
| 52 Week High | $3.214 |
| 52 Week Low | $5.11 |
| 50-Day Moving Average | $3.14 |
| 200-Day Moving Average | $8.29 |
| All data are from Alpha Vantage as of today. For more infomation on LNTH see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search